Abstract:Introduction: Obesity results from an interplay between genetic predisposition and environmental factors such as diet, physical activity, culture, and socioeconomic status. Personalized treatments for obesity would be optimal, thus necessitating the identification of individual characteristics to improve the effectiveness of therapies. For example, genetic impairment of the leptin-melanocortin pathway can result in rare cases of severe early-onset obesity. Metabolomics has the potential to distinguish between a healthy and obese status; however, differentiating subsets of individuals within the obesity spectrum remains challenging. Factor analysis can integrate patient features from diverse sources, allowing an accurate subclassification of individuals. Methods: This study presents a workflow to identify metabotypes, particularly when routine clinical studies fail in patient categorization. 110 children with obesity (BMI > +2 SDS) genotyped for nine genes involved in the leptin-melanocortin pathway (CPE, MC3R, MC4R, MRAP2, NCOA1, PCSK1, POMC, SH2B1, and SIM1) and two glutamate receptor genes (GRM7 and GRIK1) were studied; 55 harboring heterozygous rare sequence variants and 55 with no variants. Anthropometric and routine clinical laboratory data were collected, and serum samples processed for untargeted metabolomic analysis using GC-q-MS and CE-TOF-MS and reversed-phase U(H)PLC-QTOF-MS/MS in positive and negative ionization modes. Following signal processing and multialignment, multivariate and univariate statistical analyses were applied to evaluate the genetic trait association with metabolomics data and clinical and routine laboratory features. Results and Discussion: Neither the presence of a heterozygous rare sequence variant nor clinical/routine laboratory features determined subgroups in the metabolomics data. To identify metabolomic subtypes, we applied Factor Analysis, by constructing a composite matrix from the five analytical platforms. Six factors were discovered and three different metabotypes. Subtle but neat differences in the circulating lipids, as well as in insulin sensitivity could be established, which opens the possibility to personalize the treatment according to the patients categorization into such obesity subtypes. Metabotyping in clinical contexts poses challenges due to the influence of various uncontrolled variables on metabolic phenotypes. However, this strategy reveals the potential to identify subsets of patients with similar clinical diagnoses but different metabolic conditions. This approach underscores the broader applicability of Factor Analysis in metabotyping across diverse clinical scenarios.

Integrating untargeted metabolomics, genetically informed causal inference, and pathway enrichment to define the obesity metabolome

Integrative Analysis of Multi-Omics Data to Detect the Underlying Molecular Mechanisms for Obesity in Vivo in Humans

Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information.

Abstract P552: Mendelian Randomization Analysis of Metabolites Associated With Severe Obesity in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

An Atlas of Genetic Influences on Human Blood Metabolites

Integrated systems approach identifies pathways from the genome to triglycerides through a metabolomic causal network

Comparative Integrated Omics Approach Sterically Understanding Hepatic Metabolic Dynamics in Mouse Model

Computational Approaches for Systems Metabolomics

Identifying subgroups of childhood obesity by using multiplatform metabotyping

The Human Blood Metabolome-Transcriptome Interface.

Proteome and genome integration analysis of obesity

Examination of the Complex Molecular Landscape in Obesity and Type 2 Diabetes

Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases

Autonomous Multimodal Metabolomics Data Integration for Comprehensive Pathway Analysis and Systems Biology

Improving insights from metabolomic functional analysis combining multivariate tools

Genome-wide association and Mendelian randomization analysis prioritizes bioactive metabolites with putative causal effects on common diseases

An atlas of genome-wide gene expression and metabolite associations and possible mediation effects towards body mass index

Comparative Integrated Omics Approach Sterically Understanding Hepatic Metabolic Dynamics in Mouse Model: DOI: 10.5584/Jiomics.v7i1.200

Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations

Integration of metabolomics, lipidomics and clinical data using a machine learning method

Abstract EP02: Identification Of Genetic Signals For “Diabesity” --- Type 2 Diabetes And Obesity -- Among African American And European American Participants In Four Cohorts Of The TOPMed Consortium